Clinical feature	Statistical test	Significant genes	Associated with	               	Associated with	
Time from Specimen Diagnosis to Death	Cox regression test	N=645	shorter survival	N=30	longer survival	N=615
Time to Death	Cox regression test	N=0	 	 	 	 
AGE	Spearman correlation test	N=18	older	N=3	younger	N=15
PRIMARY SITE OF DISEASE	Kruskal-Wallis test	N=261	 	 	 	 
NEOPLASM DISEASESTAGE	Kruskal-Wallis test	N=2	 	 	 	 
PATHOLOGY T STAGE	Spearman correlation test	N=10	higher stage	N=1	lower stage	N=9
PATHOLOGY N STAGE	Spearman correlation test	N=7	higher stage	N=2	lower stage	N=5
PATHOLOGY M STAGE	Kruskal-Wallis test	N=0	 	 	 	 
MELANOMA ULCERATION	Wilcoxon test	N=0	 	 	 	 
MELANOMA PRIMARY KNOWN	Wilcoxon test	N=0	 	 	 	 
BRESLOW THICKNESS	Spearman correlation test	N=73	higher breslow.thickness	N=19	lower breslow.thickness	N=54
GENDER	Wilcoxon test	N=5	male	N=5	female	N=0
RACE	Kruskal-Wallis test	N=0	 	 	 	 
ETHNICITY	Wilcoxon test	N=0